These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33122009)

  • 21. Vaginal pH and microbiota during fluconazole maintenance treatment for recurrent vulvovaginal candidosis (RVVC).
    Donders GG; Grinceviciene S; Ruban K; Bellen G
    Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115024. PubMed ID: 32253071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pulsatilla decoction inhibits vulvovaginal Candida albicans proliferation and reduces inflammatory cytokine levels in vulvovaginal candidiasis mice].
    Xia D; Zhang M; Shi G; Xu Z; Wu D; Shao J; Wang T; Wang C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):153-7. PubMed ID: 26927371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of recurrent vulvovaginal candidosis with mycosyst (fluconazole)].
    Pekhlivanov B; Amaliev I; Ivancheva Kh; Zisova L
    Akush Ginekol (Sofiia); 2005; 44 Suppl 2():25-7. PubMed ID: 16028400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion.
    De Gregorio PR; Parolin C; Abruzzo A; Luppi B; Protti M; Mercolini L; Silva JA; Giordani B; Marangoni A; Nader-Macías MEF; Vitali B
    Microb Cell Fact; 2020 Jun; 19(1):133. PubMed ID: 32552788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biofilms Formed by Isolates from Recurrent Vulvovaginal Candidiasis Patients Are Heterogeneous and Insensitive to Fluconazole.
    Sherry L; Kean R; McKloud E; O'Donnell LE; Metcalfe R; Jones BL; Ramage G
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches.
    Chew SY; Than LT
    Mycoses; 2016 May; 59(5):262-73. PubMed ID: 26765516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface-modified mucoadhesive microgels as a controlled release system for miconazole nitrate to improve localized treatment of vulvovaginal candidiasis.
    Kenechukwu FC; Attama AA; Ibezim EC; Nnamani PO; Umeyor CE; Uronnachi EM; Gugu TH; Momoh MA; Ofokansi KC; Akpa PA
    Eur J Pharm Sci; 2018 Jan; 111():358-375. PubMed ID: 28986195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent vulvovaginal Candida spp isolates phenotypically express less virulence traits.
    Faria-Gonçalves P; Rolo J; Gaspar C; Oliveira AS; Pestana PG; Palmeira-de-Oliveira R; Gonçalves T; Martinez-de-Oliveira J; Palmeira-de-Oliveira A
    Microb Pathog; 2020 Nov; 148():104471. PubMed ID: 32871255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012.
    Liu XP; Fan SR; Peng YT; Zhang HP
    J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species.
    Guzel AB; Ilkit M; Akar T; Burgut R; Demir SC
    Med Mycol; 2011 Jan; 49(1):16-25. PubMed ID: 20608776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New therapeutic system based on hydrogels for vaginal candidiasis management: formulation-characterization and
    Arpa MD; Yoltaş A; Onay Tarlan E; Şenyüz CŞ; Sipahi H; Aydın A; Üstündağ Okur N
    Pharm Dev Technol; 2020 Dec; 25(10):1238-1248. PubMed ID: 32787718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam.
    Anh DN; Hung DN; Tien TV; Dinh VN; Son VT; Luong NV; Van NT; Quynh NTN; Van Tuan N; Tuan LQ; Bac ND; Luc NK; Anh LT; Trung DM
    BMC Infect Dis; 2021 Jun; 21(1):523. PubMed ID: 34082699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-related quality of life as measured with the Short-Form 36 (SF-36) questionnaire in patients with recurrent vulvovaginal candidiasis.
    Zhu YX; Li T; Fan SR; Liu XP; Liang YH; Liu P
    Health Qual Life Outcomes; 2016 Apr; 14():65. PubMed ID: 27129474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology and in vitro activity of antimycotics against candidal vaginal/skin/nail infections in Singapore.
    Kwok YK; Tay YK; Goh CL; Kamarudin A; Koh MT; Seow CS
    Int J Dermatol; 1998 Feb; 37(2):145-9. PubMed ID: 9542677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virulence Factors as Promoters of Chronic Vulvovaginal Candidosis: A Review.
    Faria-Gonçalves P; Rolo J; Gaspar C; Palmeira-de-Oliveira R; Martinez-de-Oliveira J; Palmeira-de-Oliveira A
    Mycopathologia; 2021 Dec; 186(6):755-773. PubMed ID: 34613569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
    Gao M; Wang H; Zhu L
    Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of probiotic loaded multilayer microcapsules incorporated into dissolving microneedles for potential improvement treatment of vulvovaginal candidiasis: A proof of concept study.
    Kristina Enggi C; Sulistiawati S; Stephanie S; Tangdilintin F; Anas Achmad A; Adelia Putri R; Burhanuddin H; Arjuna A; Manggau MA; Dian Permana A
    J Colloid Interface Sci; 2023 Oct; 648():203-219. PubMed ID: 37301145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biofilms and vulvovaginal candidiasis.
    Rodríguez-Cerdeira C; Gregorio MC; Molares-Vila A; López-Barcenas A; Fabbrocini G; Bardhi B; Sinani A; Sánchez-Blanco E; Arenas-Guzmán R; Hernandez-Castro R
    Colloids Surf B Biointerfaces; 2019 Feb; 174():110-125. PubMed ID: 30447520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
    Bitew A; Abebaw Y
    BMC Womens Health; 2018 Jun; 18(1):94. PubMed ID: 29902998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment.
    de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K
    J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.